At 00:25 on June 18, 2022, Beijing time, Replimune Group Inc (REPL.us) shares fluctuated and their share prices rose 10.07%. As of press time, the stock was trading at US $15.63 per share, with a turnover of 97230 shares, a turnover rate of 0.20% and an amplitude of 9.86%.
Recent financial data show that the stock has an operating income of $0.00.Net profit-$118 million, earnings per share-$2.26Gross profit-4.58 million US dollars, with a price-earnings ratio of-6.90 times.
In terms of institutional ratings, 100% of the 10 agencies that participated in the rating gave buy advice and no brokerage gave hold or sell advice.
The biotech industry in which Replimune Group Inc shares are located rose 3.5% as a whole. Among its related stocks, Biocardia Inc C/Wts 06Universe 08 Universe 2024 (To Pur Com), Scholar Rock Holding Corporation and Mereo Biopharma Group Plc rose significantly, while Kazia Therapeutics Limited, Mereo Biopharma Group Plc and Comera Life Sciences Holdings Inc were more active, with turnover rates of 91.19%, 77.80% and 61.78%, respectively. The related stocks with larger amplitudes were Scholar Rock Holding Corporation, Biocardia Inc C/Wts 06Univer 08 Universe 2024 (To Pur Com) and Sesen Bio Inc, with amplitudes of 76.34%, 63.45% and 55.93%, respectively.
About Replimune Group Inc: Replimune Group Inc is a clinical biotechnology company. The company uses a proprietary RPx platform to design and develop candidate products designed to maximize the activation of the immune system against solid tumors. The RPx platform is based on a proprietary engineering herpesvirus strain 1, or HSV-1, that adds payload to the backbone to maximize immunogenic cell death and induce systemic anti-tumor immune response. The company focuses on the development of oncolytic immunotherapy for cancer treatment. Its pipeline products include RP1, RP2 and RP3.
(the above content is completed by Money Call, a self-selected intelligent machine writer, and is only used as a reference for users to look at the market, not as a basis for transaction. )